Profile data is unavailable for this security.
About the company
ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.
- Revenue in USD (TTM)457.43m
- Net income in USD-56.05m
- Incorporated2021
- Employees2.60k
- LocationZimVie Inc10225 Westmoor DriveWESTMINSTER 80021United StatesUSA
- Phone+1 (303) 443-7500
- Websitehttps://www.zimvie.com/en
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sight Sciences Inc | 81.06m | -55.55m | 289.52m | 214.00 | -- | 2.38 | -- | 3.57 | -1.14 | -1.14 | 1.67 | 2.45 | 0.4269 | 1.70 | 5.51 | 378,761.70 | -29.26 | -38.78 | -31.77 | -42.20 | 85.34 | 80.74 | -68.53 | -105.14 | 12.65 | -10.59 | 0.2201 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Bioventus Inc | 502.76m | -122.57m | 318.46m | 970.00 | -- | 1.77 | -- | 0.6334 | -1.97 | -2.93 | 8.06 | 2.25 | 0.4552 | 2.14 | 4.10 | 448,889.30 | -14.34 | -- | -18.91 | -- | 62.87 | 70.26 | -31.51 | -9.18 | 0.9443 | 0.3731 | 0.6354 | -- | 18.85 | 11.89 | -919.12 | -- | -- | -- |
| Tactile Systems Technology Inc | 274.42m | 28.52m | 337.15m | 992.00 | 11.95 | 1.73 | 9.62 | 1.23 | 1.19 | 1.19 | 11.90 | 8.20 | 1.02 | 6.02 | 5.60 | 276,636.10 | 10.63 | 0.9015 | 13.23 | 1.09 | 49.95 | 49.10 | 10.39 | 0.8309 | 2.99 | -- | 0.1308 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
| Zynex Inc | 188.68m | 8.17m | 341.27m | 1.10k | 47.50 | 10.51 | 26.98 | 1.81 | 0.2261 | 0.2261 | 5.39 | 1.02 | 1.59 | 2.52 | 6.56 | 171,530.00 | 6.89 | 14.58 | 8.41 | 17.52 | 80.22 | 79.62 | 4.33 | 10.44 | 2.87 | 7.24 | 0.6381 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
| Pulmonx Corp | 72.99m | -58.73m | 360.21m | 279.00 | -- | 3.26 | -- | 4.93 | -1.54 | -1.54 | 1.91 | 2.85 | 0.399 | 1.14 | 7.81 | 261,627.20 | -32.11 | -26.27 | -35.87 | -28.97 | 74.31 | 71.95 | -80.46 | -93.76 | 6.14 | -- | 0.252 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
| Neuropace Inc | 65.42m | -32.96m | 386.86m | 171.00 | -- | 18.15 | -- | 5.91 | -1.28 | -1.28 | 2.53 | 0.7423 | 0.590 | 1.65 | 6.61 | 382,578.90 | -29.72 | -- | -33.88 | -- | 73.56 | -- | -50.38 | -- | 5.02 | -4.97 | 0.7339 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
| MaxCyte Inc | 41.29m | -37.92m | 408.77m | 143.00 | -- | 1.75 | -- | 9.90 | -0.3675 | -0.3675 | 0.3998 | 2.23 | 0.1488 | 0.4558 | 4.27 | 288,727.30 | -13.67 | -13.18 | -14.54 | -14.33 | 88.51 | 88.79 | -91.85 | -62.96 | 9.97 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
| Nevro Corp | 425.17m | -92.21m | 409.00m | 1.22k | -- | 1.38 | -- | 0.962 | -2.57 | -2.57 | 11.82 | 8.06 | 0.6868 | 1.24 | 5.37 | 349,937.40 | -14.90 | -13.64 | -17.15 | -16.68 | 68.22 | 68.54 | -21.69 | -20.67 | 4.94 | -- | 0.4191 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
| Pulse Biosciences Inc | 0.00 | -42.21m | 426.89m | 56.00 | -- | 9.61 | -- | -- | -0.8936 | -0.8936 | 0.00 | 0.8044 | 0.00 | -- | -- | 0.00 | -61.61 | -93.21 | -67.89 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
| ZimVie Inc | 457.43m | -56.05m | 430.64m | 2.60k | -- | 1.05 | -- | 0.9414 | -2.12 | -14.87 | 17.33 | 15.12 | 0.3213 | 1.07 | 3.91 | 175,935.80 | -3.94 | -- | -4.56 | -- | 63.48 | 65.51 | -12.25 | -8.73 | 2.32 | -0.5562 | 0.5541 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
| Surmodics Inc | 142.96m | 13.50m | 463.16m | 376.00 | 33.84 | 3.74 | 20.83 | 3.24 | 0.9597 | 0.9597 | 10.14 | 8.69 | 0.8194 | 2.05 | 6.66 | 380,220.80 | 7.74 | -1.85 | 8.69 | -2.18 | 79.11 | 82.93 | 9.44 | -2.98 | 3.59 | 9.66 | 0.1921 | -- | 32.65 | 10.27 | 94.37 | -- | -27.02 | -- |
| Orthofix Medical Inc | 746.64m | -151.40m | 505.13m | 1.63k | -- | 0.8355 | -- | 0.6765 | -4.15 | -4.15 | 20.33 | 16.11 | 1.08 | 1.62 | 7.08 | 456,940.60 | -21.88 | -8.88 | -26.68 | -10.96 | 65.13 | 72.37 | -20.28 | -9.28 | 1.20 | -16.11 | 0.1595 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| Pacific Biosciences of California Inc | 200.52m | -306.74m | 541.96m | 796.00 | -- | 0.7597 | -- | 2.70 | -1.21 | -1.21 | 0.7907 | 2.62 | 0.1142 | 2.70 | 7.24 | 251,910.80 | -17.46 | -16.19 | -19.45 | -17.81 | 28.03 | 37.35 | -152.97 | -136.21 | 7.21 | -22.45 | 0.5601 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| Nano-X Imaging Ltd | 9.91m | -60.78m | 546.01m | 164.00 | -- | 2.79 | -- | 55.12 | -1.08 | -1.08 | 0.1757 | 3.38 | 0.0419 | -- | 8.05 | 60,396.34 | -25.72 | -30.98 | -28.14 | -35.10 | -66.55 | -- | -613.59 | -1,527.24 | 5.56 | -- | 0.0175 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| Iradimed Corp | 67.69m | 17.92m | 552.03m | 148.00 | 30.98 | 7.25 | 29.47 | 8.16 | 1.41 | 1.41 | 5.31 | 6.01 | 0.8273 | 1.67 | 5.51 | 457,333.40 | 21.91 | 13.16 | 24.02 | 14.58 | 76.57 | 76.55 | 26.48 | 21.46 | 7.77 | -- | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| Jin Medical International Ltd | 19.98m | 3.25m | 565.14m | 269.00 | 161.74 | 23.76 | 157.93 | 28.29 | 0.0223 | 0.0223 | 0.1353 | 0.1519 | 0.7557 | 1.85 | 5.00 | 74,260.52 | 12.28 | -- | 16.62 | -- | 33.02 | -- | 16.25 | -- | 3.02 | -- | 0.0582 | -- | -7.58 | -- | 2.84 | -- | -- | -- |
Data as of May 07 2024. Currency figures normalised to ZimVie Inc's reporting currency: US Dollar USD
47.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Camber Capital Management LPas of 31 Dec 2023 | 3.25m | 12.00% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 1.73m | 6.37% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 1.62m | 5.97% |
| Neuberger Berman Investment Advisers LLCas of 31 Dec 2023 | 1.37m | 5.06% |
| Kent Lake Capital LLCas of 31 Dec 2023 | 1.00m | 3.69% |
| D. E. Shaw & Co. LPas of 31 Dec 2023 | 845.55k | 3.12% |
| Charles Schwab Investment Management, Inc.as of 31 Dec 2023 | 761.29k | 2.81% |
| LSV Asset Managementas of 31 Dec 2023 | 754.23k | 2.79% |
| Millennium Management LLCas of 31 Dec 2023 | 714.59k | 2.64% |
| Acadian Asset Management LLCas of 31 Dec 2023 | 694.21k | 2.56% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
